To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.



Digital PCR Market size was valued at USD 5.95 Billion in 2022 and is poised to grow from USD 6.49 Billion in 2023 to USD 13.07 Billion by 2031, at a CAGR of 9.14% during the forecast period (2024-2031).

The Digital PCR Market is highly competitive and characterized by the presence of several prominent players. These companies are focused on strategies such as mergers and acquisitions, partnerships, collaborations, and product launches to strengthen their market position. Some of the key players in the market are investing significantly in research and development activities to introduce technologically advanced digital PCR platforms and expand their product portfolios. They are also adopting various marketing strategies to enhance their brand visibility and reach a wider customer base. 'Thermo Fisher Scientific (US)', 'Bio-Rad Laboratories (US)', 'QIAGEN (Germany)', 'F. Hoffmann-La Roche Ltd (Switzerland)', 'Fluidigm Corporation (US)', 'Merck KGaA (Germany)', 'Agilent Technologies (US)', 'BioMérieux SA (France)', 'Takara Bio Inc. (Japan)', 'Danaher Corporation (US)', 'JN Medsys (Singapore)', 'RainDance Technologies (US)', 'Formulatrix, Inc. (US)', 'Stilla Technologies (France)', 'Becton, Dickinson and Company (US)', 'Analytik Jena AG (Germany)', 'Douglas Scientific (US)', 'Sysmex Corporation (Japan)', 'GenMark Diagnostics, Inc. (US)', 'Quantabio (US)'

The Molecision S6 stands as an automated, integrated digital PCR system, providing a comprehensive platform solution for research and in vitro diagnostics. Such pioneering technological advancements are anticipated to drive market growth during the forecast period from 2023 to 2030.

Integration of Digital PCR with Next-Generation Sequencing (NGS): Digital PCR and NGS technologies are complementary and can be integrated to provide comprehensive genomic analysis. The combination of digital PCR's absolute quantification capabilities with NGS's ability to provide sequencing data allows researchers to obtain both qualitative and quantitative information. This integration facilitates the identification of rare genetic variants, validation of NGS results, and analysis of complex genomic alterations in diseases.

North America, the reigning champion in the digital PCR market, continues to dominate with its advanced healthcare infrastructure, robust R&D investments, and highly developed biotechnology industry. The region's extensive adoption of digital PCR technology across multiple applications, including cancer research, infectious diseases, and personalized medicine, has propelled its market position. The presence of key market players and renowned research institutions further strengthens North America's dominance in the digital PCR landscape.

Feedback From Our Clients

Global Digital PCR Market

Product ID: SQMIG35G2206